Explore Stanford technologies available for licensing:

Stanford scientists have developed a method that utilizes specialized microbes to capture and convert dilute atmospheric carbon dioxide into reduced organic compounds.

Researchers in the Stanford School of Sustainability have patented a sustainable, cost-effective, scalable subsurface energy storage system with the potential to revolutionize solar thermal energy storage by making solar energy available 24/7 for a wide range of industrial app

Stanford scientists have discovered that novel gene therapy and metabolite supplementation approaches show promise in treating ciliopathies.

This technology developed at Stanford is a software platform for administering Stripe merchant accounts shared across large, complex organizations.

Researchers in the Airan Lab have developed a noninvasive method using low intensity transcranial ultrasound to drive cerebrospinal fluid (CSF) glymphatic and lymphatic flow to clear brain injury waste products from CSF and brain interstitium.

Stanford researchers have developed a predictive biomarker for hepatocellular carcinoma (HCC) recurrence post-treatment that provides key spatial distribution information about cell interaction.

Researchers at Stanford University and Washington University in St. Louis have discovered a novel molecular pathway for the treatment of opioid overdose.

Researchers at Stanford University have developed a novel method for the treatment and prevention of cancer.

Researchers at Stanford University have developed a novel therapeutic avenue for the treatment of osteoporosis and other musculoskeletal diseases.

Stanford researchers have developed an LVCTM3 system for producing lentiviral vectors and other viral particles, offering a cost-effective, simplified and scalable solution for various applications from gene therapy to vaccine development.

Stanford researchers have discovered that tumors increase the risk of atherosclerosis by regulating expression of a specific gene that stimulates angiogenesis and intraplaque neovessel formation.

Stanford scientists have discovered a series of compounds that inhibit PTER and leads to weight loss. They found that inhibition of PTER, a key enzyme that regulates N-acetyltaurine metabolism, leads to N-acetyltaurine accumulation and a reduction in food intake.

Stanford researchers have developed a method to overcome the packaging capacity limitation of adeno-associated virus (AAV) Vector CRISPR/Cas9 systems to help treat genetic diseases for which the cargo is larger than 4.7kb.

Quantum scientists in the LINQS, Schuster, and Simon Labs at Stanford have developed a method of multiplexing many low-light optical fields onto a single fast sensor.

Stanford researchers have developed a targeted therapy for Alzheimer's disease that focuses on inhibiting the spread of tau protein, a key factor in disease progression.